Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Charles Schwab looks like a buy here around $93.87. The franchise is producing strong revenue and FCF growth, client assets are at record levels, and the stock trades below its short-term moving averages with RSI near 37. Our trade plan: enter at $93.87, stop $86.00, target $110.00 over a 180-trading-day horizon.
Raymond James upgraded Paymentus Holdings (PAY) from Outperform to Strong Buy while trimming its price target to $35 from $41. The firm added the company to its Analyst Current Favorites list, noting recent share-price weakness and potential upside to contribution profit and adjusted EBITDA. Freedom Capital Markets also initiated coverage with a Bu…
Minutes released from the February meeting of India’s six-member monetary policy committee show most members consider the current policy rate appropriate for the economy. Two external members signalled potential for easing at some point, but several policymakers said fresh GDP data and the transmission of past cuts will guide future decisions. The …
JPMorgan upgraded Group 1 Automotive Inc. (NYSE: GPI) to Overweight from Neutral and set a $370 price target, highlighting the dealer's above-peer core fundamentals and same-store organic profit growth. The firm expects portfolio pruning - including exits from certain U.K. Jaguar Land Rover stores - to help lower leverage and improve returns even a…
Two leading sell-side firms lowered their ratings or price targets on Reliance Inc., citing deteriorating gross margins, aluminum volatility and a valuation that may not leave room for upside. J.P. Morgan set a December 2026 target of $330 while BMO trimmed its target to $320. Both analysts acknowledged Reliance's market-share gains, counter-cyclic…
JPMorgan cut Lithia Motors (NYSE: LAD) to Neutral from Overweight, pointing to outsized growth in selling, general and administrative expenses that offset flat gross profit in the fourth quarter of 2024. The bank highlighted accounting restatements and prior-year one-time SG&A benefits that raise the company’s steady-state SG&A base, reduce visibil…
Organon & Co. shares climbed 6% on Friday morning after the company's audit committee, with outside counsel support, completed an independent review and concluded there was no improper conduct related to prior biosimilar purchases from a supplier. The committee reported the review did not identify any issues requiring adjustments to previously issu…
Canaccord Genuity commenced coverage of Beam Therapeutics Inc (NASDAQ:BEAM) with a Buy rating and a $74.00 price target, flagging the company as a late clinical-stage gene-editing developer with upcoming catalysts and the capital to support an initial product launch and a subsequent pivotal program. The firm pointed to Beam's execution over the las…
Benchmark upgraded Integer Holding (ITGR) to Buy from Hold and set a $95 price target after the company posted stronger-than-expected fourth-quarter 2025 results. Revenue and adjusted EPS exceeded estimates, Cardio & Vascular sales accelerated, and management reinforced 2026 guidance while executing buybacks and announcing an additional accelerated…
Barclays has begun coverage of U.S. large-cap biopharmaceuticals with a Neutral stance, identifying Eli Lilly, Merck, Bristol-Myers Squibb and AbbVie as its top picks. The bank cites improved policy clarity after most-favored-nation agreements, demographic and healthcare spending trends, and AI-driven productivity gains as reasons the sector could …
HSBC downgraded Walmart to 'hold' from 'buy' after the retailer issued cautious full-year guidance. While quarterly results met expectations, management described the forecast as conservative amid a list of potential macro and operational risks, and near-term momentum is expected to be limited, according to HSBC analysts.
Corcept (CORT) plunged after a 12/31/2025 FDA Complete Response Letter for relacorilant tied to hypercortisolism. That sell-off priced in a lot of regulatory and litigation downside; meanwhile relacorilant's oncology potential, especially in platinum-resistant ovarian cancer, remains underappreciated. This trade idea lays out a tactical long with c…
Texas Pacific Land (TPL) is trading with clear momentum after an energy-led rally. The business earns recurring royalties, land-use fees and growing water services revenue in the Permian Basin. Valuation is rich, but a short-term momentum trade with strict risk controls is attractive: entry $487.00, stop $435.00, target $600.00 over a mid-term (45 …
J.P. Morgan has shifted to a more cautious view on European utilities, warning that possible changes to the EU Emissions Trading System (ETS) present a nearer-term threat to sector cash flows than power market restructuring. The bank also highlights tepid power demand growth and incremental LNG supply as additional pressures through 2026. Its prefe…
BofA Securities raised its rating on Tandem Diabetes Care to Neutral from Underperform and doubled its price target to $30, citing a shift into the pharmacy channel and a move toward a pay-as-you-go revenue model that could materially improve profitability. Baird separately upgraded the stock to Outperform and also set a $30 target, pointing to the…
LyondellBasell said it will cut its first-quarter dividend to 69 cents per share, citing one of the longest downturns in the chemicals industry. The company said it returned about $2 billion to shareholders in 2025 from existing cash and operations and reiterated a commitment to return 70% of free cash flow through the cycle while prioritizing safe…
LyondellBasell Industries said it will reduce its quarterly dividend from $1.37 to $0.69 per share, a 49.6 percent cut that trims the annual payout to $2.76. The dividend will be paid on March 9 to holders of record on March 2, with an ex-dividend date of Feb. 27. Management and analysts cited strained cash flows, the broader chemicals downturn and…
Blue Owl (OWL) has been hammered by redemptions, lawsuits and distribution uncertainty. The stock trades near its 52-week low with RSI around 30, heavy short interest and an attractive headline yield. We think the worst of headline-driven selling is largely priced in and propose a defined-risk long targeting a recovery to the mid-teens over a 180-t…
Turkish authorities have detained Deutsche Welle correspondent Alican Uludag in Ankara on charges of "disseminating misleading information" and "insulting the president," authorities said. The Istanbul Chief Public Prosecutor’s Office opened a criminal probe citing social media posts and said Uludag will be brought before prosecutors. Deutsche Well…
U.S. stock futures rose modestly in premarket trading as investors took a cautious stance ahead of important inflation and growth reports, while individual equities moved on company-specific news. Chipmaker Nvidia dipped slightly, several Chinese ADRs declined after a Pentagon list reference, and a range of other stocks reacted to earnings, guidanc…
Bitcoin's network, capped supply, and ongoing institutional adoption make the zero-case implausible. This trade idea lays out a clear entry at $45,000, stop at $36,000 and a $70,000 target over a 180 trading day horizon, with catalysts, valuation framing and balanced risks.
Needham has reaffirmed a Buy rating and a $40.00 price target on Five9 following fourth-quarter results that showed reaccelerating subscription revenue growth, stronger AI-related bookings and an uptick in enterprise AI revenue. The quarter included leadership changes, a strategic cloud partnership expansion, and mixed responses from other brokerag…
Cantor Fitzgerald has begun coverage of Satellogic Inc. (SATL) with an overweight rating and a $7.00 12-month price target, signaling substantial upside from the current share price. The research note highlights the company's cost advantage and underutilized capacity, alongside recent contract renewals and capital raises that support near-term oper…
Several firms planning U.S. initial public offerings in 2026 have reduced deal sizes, postponed launches or withdrawn listings as market swings and intensified valuation scrutiny weigh on the pipeline. Notable cases include Clear Street, Agibank and Liftoff Mobile. Analysts see higher IPO volume this year but warn that recent selloffs, particularly…
Bank of America has increased its year-end targets for Japan’s key equity indices, citing stronger-than-expected third-quarter corporate results and a macro-political backdrop that supports further gains. The bank now forecasts TOPIX at 4,100 and the Nikkei 225 at 61,000 by year-end, while signaling expectations for additional guidance upgrades and…
